DI BONA, DANILO
 Distribuzione geografica
Continente #
AS - Asia 2.034
EU - Europa 1.878
NA - Nord America 1.730
SA - Sud America 889
AF - Africa 60
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 6.594
Nazione #
US - Stati Uniti d'America 1.655
SG - Singapore 807
BR - Brasile 704
DE - Germania 475
VN - Vietnam 379
CN - Cina 359
RU - Federazione Russa 305
IE - Irlanda 282
HK - Hong Kong 277
FI - Finlandia 230
IT - Italia 139
UA - Ucraina 120
SE - Svezia 99
AR - Argentina 77
GB - Regno Unito 58
CZ - Repubblica Ceca 41
ID - Indonesia 41
EC - Ecuador 38
FR - Francia 37
BD - Bangladesh 28
MX - Messico 26
IN - India 25
CA - Canada 24
TR - Turchia 24
ZA - Sudafrica 20
AT - Austria 18
CO - Colombia 16
BE - Belgio 15
PY - Paraguay 15
MA - Marocco 12
PK - Pakistan 12
VE - Venezuela 12
IQ - Iraq 11
JP - Giappone 11
PE - Perù 11
LT - Lituania 10
ES - Italia 9
CL - Cile 8
PL - Polonia 8
NL - Olanda 7
SA - Arabia Saudita 7
AL - Albania 6
AM - Armenia 5
CI - Costa d'Avorio 5
DZ - Algeria 5
KZ - Kazakistan 5
NP - Nepal 5
UY - Uruguay 5
CH - Svizzera 4
DO - Repubblica Dominicana 4
LB - Libano 4
NI - Nicaragua 4
TN - Tunisia 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
BO - Bolivia 3
EG - Egitto 3
GT - Guatemala 3
IL - Israele 3
JM - Giamaica 3
JO - Giordania 3
RS - Serbia 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
GE - Georgia 2
GR - Grecia 2
KG - Kirghizistan 2
KR - Corea 2
LK - Sri Lanka 2
PS - Palestinian Territory 2
PT - Portogallo 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AO - Angola 1
AU - Australia 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
CD - Congo 1
DJ - Gibuti 1
DM - Dominica 1
EU - Europa 1
GN - Guinea 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
MZ - Mozambico 1
OM - Oman 1
PA - Panama 1
Totale 6.588
Città #
Dallas 521
Munich 415
Singapore 312
Dublin 281
Hong Kong 275
Ashburn 233
Helsinki 200
Santa Clara 144
Ho Chi Minh City 132
Beijing 100
Jacksonville 77
Hanoi 74
Moscow 55
Chandler 54
Nyköping 53
São Paulo 49
New York 48
The Dalles 46
Dearborn 45
Seattle 38
Los Angeles 37
London 28
Nanjing 28
Boardman 26
Dong Ket 26
Brno 25
Foggia 24
Princeton 23
Assago 20
Haiphong 20
Brooklyn 18
Curitiba 18
Brasília 16
Olomouc 16
Wilmington 16
Bari 15
Guayaquil 15
Brussels 14
Nuremberg 14
Rio de Janeiro 14
Biên Hòa 13
Jyväskylä 13
Hebei 11
Tokyo 11
Belo Horizonte 10
Can Tho 10
Da Nang 10
Jiaxing 10
Johannesburg 10
Mexico City 10
Porto Alegre 10
Quito 10
Council Bluffs 9
Frankfurt am Main 9
Jakarta 9
Nanchang 9
Ninh Bình 9
Salvador 9
San Francisco 9
Buenos Aires 8
Campinas 8
Falkenstein 8
Guangzhou 8
Hải Dương 8
Shenyang 8
Stevenage 8
Thái Bình 8
Toronto 8
Vienna 8
Wuhan 8
Ankara 7
Columbus 7
Fortaleza 7
Joinville 7
Montreal 7
Osasco 7
Phoenix 7
Stockholm 7
Warsaw 7
Asunción 6
Atlanta 6
Charlotte 6
Chicago 6
Dhaka 6
Duque de Caxias 6
Düsseldorf 6
Ha Long 6
São José dos Campos 6
Caracas 5
Caruaru 5
Colombo 5
Contagem 5
Des Moines 5
Guarulhos 5
Jinan 5
Kunming 5
Lima 5
Lucera 5
Manaus 5
Montevideo 5
Totale 4.021
Nome #
A 13-year real-life study on efficacy, safety and biological effects of Vespula venom immunotherapy 722
Allergic adverse events following immunization: Data from post-marketing surveillance in Apulia region (South of Italy) 195
Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence" 184
Association between the interleukin-1β polymorphisms and Alzheimer's disease: A systematic review and meta-analysis 171
Wasp immunotherapy induces a long term and IgG4-independent protection. 102
Benralizumab improves patient reported outcomes and functional parameters in difficult-to-treat patients with severe asthma: Data from a real-life cohort 90
Desensitization in Iron Product Allergy 89
KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection 83
Immunological characterization of onion (Allium cepa) allergy 83
Cost-effectiveness of grass pollen allergen immunotherapy in adults 83
Safety and treatment compliance of subcutaneous immunotherapy: A 30-year retrospective study 81
Maintenance-Phase Subcutaneous Immunotherapy with House Dust Mites Induces Cyclic Immunologic Effects 79
Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. 78
A desensitization protocol for delayed allergy to cytarabine: Analysis of two cases 78
Efficacy of grass pollen allergen sublingual immunotherapy tablets for seasonal allergic rhinoconjunctivitis. A systematic review and meta-analysis. 77
Desensitization for immediate hypersensitivity to oral dimethyl fumarate (Tecfidera) 76
Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study 74
Omalizumab in long-term treatment of refractory chronic spontaneous urticaria: effects of discontinuation. 72
Wasp immunotherapy induced long-term and IgG4-independent protection 64
Delayed allergy to acyclovir revealed by lymphocyte proliferation test 62
Rapid desensitization for brentuximab vedotin (Adceteris®) allergy: A case report 61
Dermanyssosis in the Urban Context: When the One Health Paradigm Is Put into Practice 60
Importance of Specific IgE/Total IgE Ratio in Disambiguating Amoxicillin Allergy Diagnosis in a Real-Life Setting 59
Omalizumab nell'orticaria cronica spontanea: uno studio real-life su 14 pazienti 55
La disfunzione psicosomatica delle corde vocali 55
Studi su Omalizumab nella terapia dell'asma severo. Valutazione degli effetti sulla risposta immunologica IgE in vivo. Valutazione della tollerabilità 53
Reazioni ritardate a farmaci: dal test di proliferazione linfocitaria alla desensibilizzazione 52
ARIA-Italy multidisciplinary consensus on nasal polyposis and biological treatments: Update 2025 51
[Cytomegalovirus infection in immunocompetent patients. Clinical and immunological considerations] 50
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 50
Safety of measles, mumps, and rubella vaccine in egg allergy: in vivo and in vitro management 50
An interpretable cluster-based logistic regression model, with application to the characterization of response to therapy in severe eosinophilic asthma 49
Efficacy and safety of allergen immunotherapy in patients with allergy to molds: A systematic review 48
Insulin/IGF-1 Signaling: More than a Metabolic Pathway 47
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study 46
Comparison of evidence of treatment effects in randomized and nonrandomized studies on allergen immunotherapy 45
Duration of chronic spontaneous urticaria remission after omalizumab discontinuation: A long-term observational study 44
A Multicenter Study on the Prevalence of Clinical Patterns and Clinical Phenotypes in Adult Atopic Dermatitis 44
A 300 IR 5-grass pollen sublingual immunotherapy tablet-specific systematic review and meta-analysis confirms its clinical benefits for patients with allergic rhinoconjunctivitis with or without asthma 44
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 44
Dupilumab in atopic dermatitis: predictors of treatment outcome and time to response 43
Arterial stiffness, endothelial and cognitive function in subjects with type 2 diabetes in accordance with absence or presence of diabetic foot syndrome 43
Omalizumab in long-term treatment of refractory chronic spontaneus urticaria:effects of discontinuation 42
Association between γ marker, human leucocyte antigens and killer immunoglobulin-like receptors and the natural course of human cytomegalovirus infection: a pilot study performed in a Sicilian population 42
Association between genetic variations in the insulin/insulin-like growth factor (Igf-1) signaling pathway and longevity: a systematic review and meta-analysis 41
ARIA-Italy multidisciplinary consensus on nasal polyposis and biological treatments: Update 2025 41
Dupilumab elicits a favorable response in type-2 inflammatory comorbidities of severe atopic dermatitis 41
Efficacy of allergen immunotherapy in reducing the likelihood of developing new allergen sensitizations: a systematic review 41
Efficacy of index of reactivity-liquid sublingual immunotherapy in allergic rhinoconjunctivitis: a systematic review and meta-analysis of randomized studies 40
[Role of combination NK/KIRs in the natural history of viral infections.] 40
Chronic urticaria reveals JAK2V617F positive essential thrombocythemia 40
Role of immunogenetics in the outcome of HCMV infection: Implications for ageing 40
Efficacy of grass pollen allergen sublingual immunotherapy tablets for seasonal allergic rhinoconjunctivitis: A systematic review and meta-analysis 39
Albumin versus solvent/detergent-treated pooled plasma as replacement fluid for long-term plasma exchange therapy in a patient with primary hypertriglyceridemia and recurrent hyperlipidemic pancreatitis 38
Association between interleukin-10 polymorphisms and alzheimer's disease: A systematic review and meta-analysis 38
Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis 37
Translation of basic research into clinics: Killer immunoglobulin-like receptors genes in autoimmune and infectious diseases 37
Latex Allergy – From Discovery to Component-resolved Diagnosis 36
Desensitization in Iron Product Allergy 36
Planned omalizumab discontinuation in CSU management as a sustainable strategy: A 2‐year real‐life study 36
An Update on Nonsteroidal Anti-Inflammatory Drug-Induced Urticaria 36
Two-year follow-up after drug desensitization in mucopolysaccharidosis 36
Severe asthma and personalized approach in the choice of biologic 36
Editorial: pharmacotherapy and evidence-based medicine in allergy and clinical immunology-2025 updates and perspectives 35
Transcriptomic in allergy–statistical recommendations 35
HLA and KIR Interaction in Patients with Ischemic Stroke 35
Biologics in severe asthma: the role of real-world evidence from registries 34
Allergic contact dermatitis from vitamins: A systematic review 34
Editorial: pharmacotherapy and evidence-based medicine 34
HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke 34
Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis 34
Benralizumab improves patient reported outcomes and functional parameters in difficult-to-treat patients with severe asthma: Data from a real-life cohort 33
IR (index of reactivity)-house dust mite sublingual immunotherapy liquid formulation for allergic rhinoconjunctivitis: Systematic review and meta-analysis of randomized and nonrandomized studies 33
Association of klotho polymorphisms with healthy aging: A systematic review and meta-analysis 33
Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis 33
Real-world effectiveness of mepolizumab in asthma: a systematic review and meta-analysis 32
Israeli Spotted Fever in Sicily. Description of two cases and minireview 31
The impact of antiviral treatments on the course of chronic hepatitis C: An evidence-based approach 31
In Vivo and In Vitro Assessment and Proteomic Analysis of the Effectiveness of Physical Treatments in Reducing Allergenicity of Hazelnut Proteins 31
Statistical advice provided by ChatGPT regarding an accepted article in Allergy 31
Distribution of KIR Genes and Their HLA Ligands in Different Viral Infectious Diseases: Frequency Study in Sicilian Population 31
Use of Dupilumab for 543 Adult Patients with Moderate-To-Severe Atopic Dermatitis: A Multicenter, Retrospective Study 30
Efficacy and Safety of Mepolizumab 300 mg in Eosinophilic Granulomatosis With Polyangiitis: A Meta-Analysis of Eight Retrospective Studies 30
Immunological and non-immunological mechanisms of allergic diseases in the elderly: Biological and clinical characteristics 30
Novel approach to idursulfase and laronidase desensitization in type 2 and type 1 S mucopolysaccharidosis (MPS) 30
Targeting aging with functional food: Pasta with opuntia single-arm pilot study 30
Severe asthma: One disease and multiple definitions 30
Meta‐analysis in allergy—Statistical recommendations 30
Polymorphisms of pro-inflammatory genes and prostate cancer risk: A pharmacogenomic approach 29
Hypersensitivity reaction during enzyme replacement therapy in lysosomal storage disorders. A systematic review of desensitization strategies 29
The POU-domain transcription factor Oct-6/POU3F1 as a regulator of cellular response to genotoxic stress 29
HLA-C1 ligands are associated with increased susceptibility to systemic lupus erythematosus 28
Early high-dosage atorvastatin treatment improved serum immune-inflammatory markers and functional outcome in acute ischemic strokes classified as large artery atherosclerotic stroke: A randomized trial 28
The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms 28
Immune-inflammatory and metabolic effects of high dose furosemide plus hypertonic saline solution (HSS) treatment in cirrhotic subjects with refractory ascites 28
Editorial introductions 28
Sublingual immunotherapy with natural grass pollen extracts: An appraisal of the evidence 28
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 28
The immunoglobulin γ marker 17 allotype and KIR/HLA genes prevent the development of chronic hepatitis B in humans 27
Sex and Gender in Ageing and Longevity: Highlights From an International Course 27
Totale 5.590
Categoria #
all - tutte 45.343
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.343


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021155 0 0 0 0 0 4 21 38 32 31 0 29
2021/2022138 4 0 2 3 17 10 1 6 33 12 7 43
2022/2023443 72 16 13 12 9 22 4 32 234 15 7 7
2023/2024647 11 2 303 3 23 121 13 52 3 9 7 100
2024/20252.465 84 27 61 23 71 327 387 235 671 111 132 336
2025/20262.922 303 390 1.005 1.027 133 64 0 0 0 0 0 0
Totale 7.148